Congenital defects in neutrophil dynamics

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Keszei, Marton ^a   Westerberg, Lisa S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 PHOSPHONOPROPIONIC ACID; LEUKOCYTE ELASTASE; ACTIN;

ACTIN FILAMENT; ACTIN POLYMERIZATION; CELL MIGRATION; CELLULAR SECRETION; CHEDIAK HIGASHI SYNDROME; CHRONIC GRANULOMATOUS DISEASE; CONGENITAL DISORDER; HEMATOPOIETIC CELL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPOPIGMENTATION; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; LEUKOCYTE ADHERENCE; LEUKOCYTE ADHESION DEFICIENCY; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; RESPIRATORY BURST; REVIEW; SEVERE CONGENITAL NEUTROPENIA; VERRUCA VULGARIS; WISKOTT ALDRICH SYNDROME; ANIMAL; CELL ADHESION; GENETICS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; METABOLISM; NEUTROPHIL; TRANSPORT VESICLE;

ACTINS; ANIMALS; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; NEUTROPHILS; TRANSPORT VESICLES;

EID: 84929138345     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/303782     Document Type: Review

References (130)

1. CEREDIH: The French PID study group, "The French national registry of primary immunodeficiency diseases, " Clinical Immunology, vol. 135, no. 2, pp. 264-272, 2010.
2. J. Donadieu, O. Fenneteau, B. Beaupain, N. Mahlaoui, and C. B. Chantelot, "Congenital neutropenia: diagnosis, molecular bases and patient management, " Orphanet Journal of Rare Diseases, vol. 6, no. 1, article 26, 2011.
3. T. D. Pollard and G. G. Borisy, "Cellular motility driven by assembly and disassembly of actin filaments, " Cell, vol. 112, no. 4, pp. 453-465, 2003.
4. R. Meili and R. A. Firtel, "Two poles and a compass, " Cell, vol. 114, no. 2, pp. 153-156, 2003.
5. T. M. Bunnell, B. J. Burbach, Y. Shimizu, and J. M. Ervasti, " β-Actin specifically controls cell growth, migration, and the Gactin pool, " Molecular Biology of the Cell, vol. 22, no. 21, pp. 4047-4058, 2011.
6. W. Shawlot, J. M. Deng, L. E. Fohn, and R. R. Behringer, "Restricted β-galactosidase expression of a hygromycin-lacZ gene targeted to the β-actin locus and embryonic lethality of β-actin mutant mice, " Transgenic Research, vol. 7, no. 2, pp. 95-103, 1998.
7. H. Nunoi, T. Yamazaki, H. Tsuchiya, et al., "A heterozygous mutation of β-actin associated with neutrophil dysfunction and recurrent infection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8693-8698, 1999.
8. V. Procaccio, G. Salazar, S. Ono, et al., "A mutation of β-actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia, "The American Journal ofHuman Genetics, vol. 78, no. 6, pp. 947-960, 2006.
9. J. B. Rivière, B. W. van Bon, A. Hoischen, et al., "De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome, " Nature Genetics, vol. 44, no. 4, pp. 440-444, 2012.
10. N. di Donato, A. Rump, R. Koenig, et al., "Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations, " European Journal of Human Genetics, vol. 22, pp. 179-183, 2014.
11. J. J. Johnston, K. K. Wen, K. Keppler-Noreuil, et al., "Functional analysis of a de novo ACTB mutation in a patient with atypical Baraitser-Winter syndrome, " Human Mutation, vol. 34, no. 9, pp. 1242-1249, 2013.
12. D. A. Moulding, J. Record, D. Malinova, and A. J. Thrasher, "Actin cytoskeletal defects in immunodeficiency, " Immunological Reviews, vol. 256, pp. 282-299, 2013.
13. M. J. Massaad, N. Ramesh, and R. S. Geha, "Wiskott-Aldrich syndrome: a comprehensive review, " Annals of the New York Academy of Sciences, vol. 1285, no. 1, pp. 26-43, 2013.
14. H. Zhang, U. Y. Schaff, C. E. Green, et al., "Impaired integrindependent function in Wiskott-Aldrich syndrome proteindeficientmurine and human neutrophils, " Immunity, vol. 25, no. 2, pp. 285-295, 2006.
15. S. B. Snapper, P. Meelu, D. Nguyenet al., "WASPdeficiency leads to global defects of directed leukocyte migration in vitro and in vivo, " Journal of Leukocyte Biology, vol. 77, no. 6, pp. 993-998, 2005.
16. S. Kumar, J. Xu, C. Perkins, et al., "Cdc42 regulates neutrophil migration via crosstalk between WASp, CD11b, and microtubules, " Blood, vol. 120, no. 17, pp. 3563-3574, 2012.
17. K. Devriendt, A. S. Kim, G. Mathijs, et al., "Constitutively activatingmutation inWASP causes X-linked severe congenital neutropenia, " Nature Genetics, vol. 27, no. 3, pp. 313-317, 2001.
18. P. J. Ancliff, M. P. Blundell, G. O. Cory, et al., "Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia, " Blood, vol. 108, no. 7, pp. 2182-2189, 2006.
19. D. A. Moulding, M. P. Blundell, D. G. Spiller, et al., "Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia, "The Journal of Experimental Medicine, vol. 204, no. 9, pp. 2213-2224, 2007.
20. K. Beel, M. M. Cotter, J. Blatny, et al., "A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene, " British Journal of Haematology, vol. 144, no. 1, pp. 120-126, 2009.
21. S. O. Burns, D. J. Killock, D. A. Moulding, et al., "A congenital activating mutant of WASp causes altered plasma membrane topography and adhesion under flow in lymphocytes, " Blood, vol. 115, no. 26, pp. 5355-5365, 2010.
22. L. S. Westerberg, P. Meelu, M. Baptista, et al., "Activating WASPmutations associatedwithX-linkedneutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes, " Journal of Experimental Medicine, vol. 207, no. 6, pp. 1145-1152, 2010.
23. D. A. Moulding, E. Moeendarbary, L. Valon, J. Record, G. T. Charras, and A. J. Thrasher, "Excess F-actin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutropenia by exceeding Aurora B kinase error correction capacity, " Blood, vol. 120, no. 18, pp. 3803-3811, 2012.
24. A. R. Houk, A. Jilkine, C. O. Mejean, et al., "Membrane tension maintains cell polarity by confining signals to the leading edge during neutrophilmigration, " Cell, vol. 148, no. 1-2, pp. 175-188, 2012.
25. A. W. Roberts, C. Kim, L. Zhen, et al., "Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense, " Immunity, vol. 10, no. 2, pp. 183-196, 1999.
26. P. Aspenstrom, "BAR domain proteins regulate Rho GTPase signaling, " Small GTPases, vol. 5, Article IDe28580, 2014.
27. M. C. Dinauer, "Regulation of neutrophil function by Rac GTPases, " Current Opinion in Hematology, vol. 10, no. 1, pp. 8-15, 2003.
28. D. R. Ambruso, C. Knall, A. N. Abell, et al., "Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2mutation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 9, pp. 4654-4659, 2000.
29. D. A. Williams, W. Tao, F. Yang, et al., "Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency, " Blood, vol. 96, no. 5, pp. 1646-1654, 2000.
30. D. Accetta, G. Syverson, B. Bonacci, et al., "Human phagocyte defect caused by a Rac2mutation detected bymeans of neonatal screening for T-cell lymphopenia, " The Journal of Allergy and Clinical Immunology, vol. 127, no. 2, pp. 535. e2-538. e2, 2011.
31. M. C. Dinauer, "Chronic granulomatous disease and other disorders of phagocyte function, " Hematology/the Education Program of the American Society of Hematology: American Society of Hematology: Education Program, no. 1, pp. 89-95, 2005.
32. J. S. Kim, T. Y. Huang, and G. M. Bokoch, "Reactive oxygen species regulate a slingshot-cofilin activation pathway, " Molecular Biology of the Cell, vol. 20, no. 11, pp. 2650-2660, 2009.
33. J. van Rheenen, J. Condeelis, and M. Glogauer, "A common cofilin activity cycle in invasive tumor cells and inflammatory cells, " Journal of Cell Science, vol. 122, no. 3, pp. 305-311, 2009.
34. A. S. Nimnual, L. J. Taylor, and D. Bar-Sagi, "Redox-dependent downregulation of Rho by Rac, " Nature Cell Biology, vol. 5, no. 3, pp. 236-241, 2003.
35. E. P. Reeves, H. Lu, H. L. Jacobs, et al., "Killing activity of neutrophils is mediated through activation of proteases by K+ flux, " Nature, vol. 416, no. 6878, pp. 291-297, 2002.
36. L. A. Boxer, E. T. HedleyWhyte, and T. P. Stossel, "Neutrophil actin dysfunction and abnormal neutrophil behavior, " The New England Journal ofMedicine, vol. 291, no. 21, pp. 1093-1099, 1974.
37. F. S. Southwick, G. A. Dabiri, and T. P. Stossel, "Neutrophil actin dysfunction is a genetic disorder associated with partial impairment of neutrophil actin assembly in three family members, " The Journal of Clinical Investigation, vol. 82, no. 5, pp. 1525-1531, 1988.
38. F. S. Southwick, T. H. Howard, T. Holbrook, D. C. Anderson, T. P. Stossel, and M. A. Arnaout, "The relationship between CR3 deficiency and neutrophil actin assembly, " Blood, vol. 73, no. 7, pp. 1973-1979, 1989.
39. T. D. Coates, J. C. Torkildson, M. Torres, J. A. Church, and T. H. Howard, "An inherited defect of neutrophil motility and microfilamentous cytoskeleton associated with abnormalities in 47-Kd and 89-Kd proteins, " Blood, vol. 78, no. 5, pp. 1338-1346, 1991.
40. T. Howard, Y. Li, M. Torres, A. Guerrero, and T. Coates, "The 47-kD protein increased in neutrophil actin dysfunction with 47-and 89-kD protein abnormalities is lymphocyte-specific protein, " Blood, vol. 83, no. 1, pp. 231-241, 1994.
41. Y. Li, A. Guerrero, and T. H. Howard, "The actin-binding protein, lymphocyte-specific protein 1, is expressed in human leukocytes and humanmyeloid and lymphoid cell lines, " Journal of Immunology, vol. 155, no. 7, pp. 3563-3569, 1995.
42. T. H. Howard, J. Hartwig, and C. Cunningham, "Lymphocytespecific protein 1 expression in eukaryotic cells reproduces the morphologic and motile abnormality of NAD 47/89 neutrophils, " Blood, vol. 91, no. 12, pp. 4786-4795, 1998.
43. J. Jongstra-Bilen, V. L. Misener, C. Wang, et al., "LSP1modulates leukocyte populations in resting and inflamed peritoneum, " Blood, vol. 96, no. 5, pp. 1827-1835, 2000.
44. E. van de Vijver, T. K. van den Berg, and T. W. Kuijpers, "Leukocyte adhesion deficiencies, " Hematology/Oncology Clinics of North America, vol. 27, no. 1, pp. 101-116, 2013.
45. I. Delon and N. H. Brown, "Integrins and the actin cytoskeleton, " Current Opinion in Cell Biology, vol. 19, no. 1, pp. 43-50, 2007.
46. K. A. DeMali, K. Wennerberg, and K. Burridge, "Integrin signaling to the actin cytoskeleton, " Current Opinion in Cell Biology, vol. 15, no. 5, pp. 572-582, 2003.
47. T. Kinashi, "Intracellular signalling controlling integrin activation in lymphocytes, " Nature Reviews Immunology, vol. 5, no. 7, pp. 546-559, 2005.
48. F. Hauck and C. Klein, "Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes, " Current Opinion in Allergy and Clinical Immunology, vol. 13, pp. 596-606, 2013.
49. C. Klein, M. Grudzien, G. Appaswamy, et al., "HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease), " Nature Genetics, vol. 39, no. 1, pp. 86-92, 2007.
50. Y. Suzuki, C. Demoliere, D. Kitamura, H. Takeshita, U. Deuschle, and T. Watanabe, "HAX-1, a novel intracellular protein, localized on Mitochondria, directly associates with HS1, a substrate of Src family Tyrosine kinases, " Journal of Immunology, vol. 158, no. 6, pp. 2736-2744, 1997.
51. L. Cilenti, M. M. Soundarapandian, G. A. Kyriazis, et al., "Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death, "The Journal of Biological Chemistry, vol. 279, no. 48, pp. 50295-50301, 2004.
52. T. V. Sharp, H. W. Wang, A. Koumi, et al., "K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function, " Journal of Virology, vol. 76, no. 2, pp. 802-816, 2002.
53. A. R. Gallagher, A. Cedzich, N. Gretz, S. Somlo, and R. Witzgall, "Thepolycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 8, pp. 4017-4022, 2000.
54. A. G. Ramsay, M. D. Keppler, M. Jazayeri, et al., "HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin αvβ6, " Cancer Research, vol. 67, no. 11, pp. 5275-5284, 2007.
55. V. Radhika, D. Onesime, J. H. Ha, and N. Dhanasekaran, "G13 stimulates cell migration through cortactin-interacting protein Hax-1, "The Journal of Biological Chemistry, vol. 279, no. 47, pp. 49406-49413, 2004.
56. P. J. Cavnar, E. Berthier, D. J. Beebe, and A. Huttenlocher, "Hax1 regulates neutrophil adhesion and motility through RhoA, " Journal of Cell Biology, vol. 193, no. 3, pp. 465-473, 2011.
57. P. A. Hernandez, R. J. Gorlin, J. N. Lukens, et al., "Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease, " Nature Genetics, vol. 34, no. 1, pp. 70-74, 2003.
58. C. Martin, P. C. E. Burdon, G. Bridger, J. Gutierrez-Ramos, T. J. Williams, and S. M. Rankin, "Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence, " Immunity, vol. 19, no. 4, pp. 583-593, 2003.
59. B. T. Suratt, J. M. Petty, S. K. Young, et al., "Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis, " Blood, vol. 104, no. 2, pp. 565-571, 2004.
60. T. Kawai and H. L. Malech, "WHIM syndrome: congenital immune deficiency disease, " Current Opinion in Hematology, vol. 16, no. 1, pp. 20-26, 2009.
61. K. Balabanian, B. Lagane, J. L. Pablos, et al., "WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, " Blood, vol. 105, no. 6, pp. 2449-2457, 2005.
62. T. Kawai, U. Choi, L. Cardwell, et al., "WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncatedCXCR4, " Blood, vol. 109, no. 1, pp. 78-84, 2007.
63. K. B. Walters, J. M. Green, J. C. Surfus, S. K. Yoo, and A. Huttenlocher, "Live imaging of neutrophil motility in a zebrafish model ofWHIM syndrome, " Blood, vol. 116, no. 15, pp. 2803-2811, 2010.
64. N. Borregaard and J. B. Cowland, "Granules of the human neutrophilic polymorphonuclear leukocyte, " Blood, vol. 89, no. 10, pp. 3503-3521, 1997.
65. P. Aspenstrom, "Roles of F-BAR/PCH proteins in the regulation of membrane dynamics and actin reorganization, " International Review of Cell and Molecular Biology, vol. 272, pp. 1-31, 2008.
66. P. Aspenstrom, U. Lindberg, and A. Hall, "TwoGTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorderWiskott-Aldrich syndrome, " Current Biology, vol. 6, no. 1, pp. 70-75, 1996.
67. R. Rohatgi, L. Ma, H. Miki, et al., "The interaction between NWASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly, " Cell, vol. 97, no. 2, pp. 221-231, 1999.
68. J. Stinchcombe, G. Bossi, and G. M. Giffiths, "Linking albinism and immunity: the secrets of secretory lysosomes, " Science, vol. 305, no. 5680, pp. 55-59, 2004.
69. J. Kaplan, I. De Domenico, and D. M. Ward, "Chediak-Higashi syndrome, " Current Opinion in Hematology, vol. 15, no. 1, pp. 22-29, 2008.
70. R. S. Blume, J. M. Bennett, R. A. Yankee, and S. M. Wolff, "Defective granulocyte regulation in the Chediak-Higashi syndrome, " The New England Journal ofMedicine, vol. 279, no. 19, pp. 1009-1015, 1968.
71. R. A. Clark and H. R. Kimball, "Defective granulocyte chemotaxis in the Chediak-Higashi syndrome, " Journal of Clinical Investigation, vol. 50, no. 12, pp. 2645-2652, 1971.
72. R. K. Root, A. S. Rosenthal, and D. J. Balestra, "Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes, "The Journal of Clinical Investigation, vol. 51, no. 3, pp. 649-665, 1972.
73. T. Ganz, J. A. Metcalf, J. I. Gallin, L. A. Boxer, and R. I. Lehrer, "Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency, " Journal of Clinical Investigation, vol. 82, no. 2, pp. 552-556, 1988.
74. L. Kjeldsen, J. Calafat, and N. Borregaard, "Giant granules of neutrophils in Chediak-Higashi syndrome are derived from azurophil granules but not from specific and gelatinase granules, " Journal of Leukocyte Biology, vol. 64, no. 1, pp. 72-77, 1998.
75. M. D. F. S. Barbosa, Q. A. Nguyen, V. T. Tchernev, et al., "Identification of the homologous beige and Chediak-Higashi syndrome genes, " Nature, vol. 382, no. 6588, pp. 262-265, 1996.
76. C. Griscelli, A. Durandy, D. Guy-Grand, F. Daguillard, C. Herzog, and M. A. Prunieras, "A syndrome associating partial albinism and immunodeficiency, " The American Journal of Medicine, vol. 65, no. 4, pp. 691-702, 1978.
77. G. Menasche, E. Pastural, J. Feldmann, et al., "Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome, " Nature Genetics, vol. 25, no. 2, pp. 173-176, 2000.
78. J. L. Johnson, A. A. Brzezinska, T. Tolmachova, et al., "Rab27a and Rab27b regulate neutrophil azurophilic granule exocytosis and NADPH oxidase activity by independent mechanisms, " Traffic, vol. 11, no. 4, pp. 533-547, 2010.
79. R. K. Singh, W. Liao, D. Tracey-White, et al., "Rab27a-mediated protease release regulates neutrophil recruitment by allowing uropod detachment, " Journal of Cell Science, vol. 125, no. 7, pp. 1652-1656, 2012.
80. D. B. Munafo, J. L. Johnson, B. A. Ellis, S. Rutschmann, B. Beutler, and S. D. Catz, "Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes, " The Biochemical Journal, vol. 402, no. 2, pp. 229-239, 2007.
81. G. Bohn, A. Allroth, G. Brandes, et al., "A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14, " Nature Medicine, vol. 13, no. 1, pp. 38-45, 2007.
82. M. Horwitz, K. F. Benson, R. E. Person, A. G. Aprikyan, and D. C. Dale, "Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis, " Nature Genetics, vol. 23, no. 4, pp. 433-436, 1999.
83. M. S. Horwitz, Z. Duan, B. Korkmaz, H. Lee, M. E. Mealiffe, and S. J. Salipante, "Neutrophil elastase in cyclic and severe congenital neutropenia, " Blood, vol. 109, no. 5, pp. 1817-1824, 2007.
84. D. C. Dale, R. E. Person, A. A. Bolyard, et al., "Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia, " Blood, vol. 96, no. 7, pp. 2317-2322, 2000.
85. T. Tidwell, J. Wechsler, R. C. Nayak, et al., "Neutropeniaassociated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms, " Blood, vol. 123, pp. 562-569, 2014.
86. J. Xia and D. C. Link, "Severe congenital neutropenia and the unfolded protein response, " Current Opinion in Hematology, vol. 15, no. 1, pp. 1-7, 2008.
87. V. Shotelersuk, E. C. DellAngelica, L. Hartnell, J. S. Bonifacino, and W. A. Gahl, "A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation, " The American Journal of Medicine, vol. 108, no. 5, pp. 423-427, 2000.
88. E. C. DellAngelica, V. Shotelersuk, R. C. Aguilar, W. A. Gahl, and J. S. Bonifacino, "Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β3A subunit of the AP-3 adaptor, " Molecular Cell, vol. 3, no. 1, pp. 11-21, 1999.
89. K. F. Benson, F. Li, R. E. Personet al., "Mutations associatedwith neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase, " Nature Genetics, vol. 35, no. 1, pp. 90-96, 2003.
90. I. Kollner, B. Sodeik, S. Schreek, et al., "Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response, " Blood, vol. 108, no. 2, pp. 493-500, 2006.
91. D. S. Grenda, M. Murakami, J. Ghatak, et al., "Mutations of the ELA2 gene found in patientswith severe congenital neutropenia induce the unfolded protein response and cellular apoptosis, " Blood, vol. 110, no. 13, pp. 4179-4187, 2007.
92. R. E. Person, F. Li, Z. Duan, et al., "Mutations in protooncogene GFI1 cause human neutropenia and target ELA2, " Nature Genetics, vol. 34, no. 3, pp. 308-312, 2003.
93. S. Zuchner, M. Noureddine, M. Kennerson, et al., "Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease, " Nature Genetics, vol. 37, no. 3, pp. 289-294, 2005.
94. M. M. Cohen, B. D. Hall, D. W. Smith, C. B. Graham, and K. J. Lampert, "A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies, " The Journal of Pediatrics, vol. 83, pp. 280-284, 1973.
95. S. Kivitie-Kallio, J. Rajantie, E. Juvonen, and R. Norio, "Granulocytopenia in Cohen syndrome, " British Journal of Haematology, vol. 98, no. 2, pp. 308-311, 1997.
96. O. Olivieri, S. Lombardi, C. Russo, and R. Corrocher, "Increased neutrophil adhesive capability in Cohen syndrome, an autosomal recessive disorder associated with granulocytopenia, " Haematologica, vol. 83, no. 9, pp. 778-782, 1998.
97. J. Kolehmainen, G. C. M. Black, A. Saarinen, et al., "Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport, " The American Journal of Human Genetics, vol. 72, no. 6, pp. 1359-1369, 2003.
98. T. Vilboux, A. Lev, M. C. V. Malicdan, et al., "A congenital neutrophil defect syndrome associated with mutations in VPS45, " The New England Journal of Medicine, vol. 369, no. 1, pp. 54-65, 2013.
99. P. Stepensky, A. Saada, M. Cowan, et al., "The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy., " Blood, vol. 121, no. 25, pp. 5078-5087, 2013.
100. K. Boztug, G. Appaswamy, A. Ashikov, et al., "A syndrome with congenital neutropenia and mutations in G6PC3, " The New England Journal of Medicine, vol. 360, no. 1, pp. 32-43, 2009.
101. I. Gerin, M. Veiga-da-Cunha, Y. Achouri, J. F. Collet, and E. van Schaftingen, "Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib, " The FEBS Letters, vol. 419, no. 2-3, pp. 235-238, 1997.
102. K. Narisawa, Y. Igarashi, H. Otomo, and K. Tada, "Anewvarient of glycogen storage disease Type I probably due to a defect in the glucose-6-phosphate transport system, " Biochemical and Biophysical Research Communications, vol. 83, no. 4, pp. 1360-1364, 1978.
103. Y. Y. Cheung, S. Y. Kim, W. H. Yiu, et al., "Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-β, " The Journal of Clinical Investigation, vol. 117, no. 3, pp. 784-793, 2007.
104. H. S. Jun, D. A. Weinstein, Y. M. Lee, B. C. Mansfield, and J. Y. Chou, "Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib, " Blood, vol. 123, pp. 2843-2853, 2014.
105. C. Toomes, J. James, A. J. Wood, et al., "Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis, " Nature Genetics, vol. 23, no. 4, pp. 421-424, 1999.
106. T. C. Hart, P. S. Hart, D. W. Bowden, et al., "Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome, " Journal of Medical Genetics, vol. 36, no. 12, pp. 881-887, 1999.
107. N. V. Rao, G. V. Rao, and J. R. Hoidal, "Human dipeptidylpeptidase I: gene characterization, localization, and expression, " The Journal of Biological Chemistry, vol. 272, no. 15, pp. 10260-10265, 1997.
108. M. J. McGuire, P. E. Lipsky, and D. L. Thiele, "Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I, " Journal of Biological Chemistry, vol. 268, no. 4, pp. 2458-2467, 1993.
109. A. M. Adkison, S. Z. Raptis, D. G. Kelley, and C. T. N. Pham, "Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis, "The Journal of Clinical Investigation, vol. 109, no. 3, pp. 363-371, 2002.
110. E. Haneke, "The Papillon-Lefevre syndrome: keratosis palmoplantaris with periodontopathy. Report of a case and review of the cases in the literature, " Human Genetics, vol. 51, no. 1, pp. 1-35, 1979.
111. E. Firatli, B. Tuzun, and A. Efeoglu, "Papillon-Lefèvre syndrome: analysis of neutrophil chemotaxis, " Journal of Periodontology, vol. 67, no. 6, pp. 617-620, 1996.
112. O. P. Smith, "Shwachman-Diamond syndrome, " Seminars in Hematology, vol. 39, no. 2, pp. 95-102, 2002.
113. V. Stepanovic, D. Wessels, F. D. Goldman, J. Geiger, and D. R. Soll, "The chemotaxis defect of Shwachman-Diamond Syndrome leukocytes, " Cell Motility and the Cytoskeleton, vol. 57, no. 3, pp. 158-174, 2004.
114. C. Orelio and T. W. Kuijpers, "Shwachman-diamond syndrome neutrophils have altered chemoattractant-induced Factin polymerization and polarization characteristics, " Haematologica, vol. 94, no. 3, pp. 409-413, 2009.
115. G. R. B. Boocock, J. A. Morrison, M. Popovic, et al., "Mutations in SBDS are associated with Shwachman-Diamond syndrome, " Nature Genetics, vol. 33, no. 1, pp. 97-101, 2003.
116. G. Ram and J. Chinen, "Infections and immunodeficiency in Down syndrome, " Clinical and Experimental Immunology, vol. 164, no. 1, pp. 9-16, 2011.
117. E. Novo, M. I. Garcia, and J. Lavergne, "Nonspecific immunity in Down syndrome: a study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of polymorphonuclear cells, " The American Journal of Medical Genetics, vol. 46, no. 4, pp. 384-391, 1993.
118. J. Pillay, I. den Braber, N. Vrisekoop, et al., "In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5. 4 days, " Blood, vol. 116, no. 4, pp. 625-627, 2010.
119. S. von Vietinghoff and K. Ley, "Homeostatic regulation of blood neutrophil counts, " The Journal of Immunology, vol. 181, no. 8, pp. 5183-5188, 2008.
120. P. C. E. Burdon, C. Martin, and S. M. Rankin, "Migration across the sinusoidal endothelium regulates neutrophil mobilization in response to ELR + CXC chemokines, " British Journal of Haematology, vol. 142, no. 1, pp. 100-108, 2008.
121. H. Saito, J. Lai, R. Rogers, and C. M. Doerschuk, "Mechanical properties of rat bone marrow and circulating neutrophils and their responses to inflammatory mediators, " Blood, vol. 99, no. 6, pp. 2207-2213, 2002.
122. B. R. Schwartz, E. A. Wayner, T. M. Carlos, H. D. Ochs, and J. M. Harlan, "Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium, " Journal of Clinical Investigation, vol. 85, no. 6, pp. 2019-2022, 1990.
123. A. A. Schaffer and C. Klein, "Animal models of human granulocyte diseases, "Hematology/Oncology Clinics ofNorthAmerica, vol. 27, no. 1, pp. 129-148, 2013.
124. A. Belaaouaj, R. Mccarthy, M. Baumann, et al., "Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis, " Nature Medicine, vol. 4, no. 5, pp. 615-618, 1998.
125. TheJacksonLaboratory, "Hematological survey of 11 inbred strains of mice, " MPD: Jaxpheno4, Mouse Phenome Database web site, The Jackson Laboratory, Bar Harbor, Me, USA, 2014, http://www.phenome.jax.org/.
126. L. Wakeman, S. Al-Ismail, A. Benton, et al., "Robust, routine haematology reference ranges for healthy adults, " International Journal of Laboratory Hematology, vol. 29, no. 4, pp. 279-283, 2007.
127. H. Bjorgvinsd?ttir, C. Ding, N. Pech, M. A. Gifford, L. L. Li, and M. C. Dinauer, "Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease, " Blood, vol. 89, no. 1, pp. 41-48, 1997.
128. M. Mardiney III, S. H. Jackson, S. K. Spratt, F. Li, S. M. Holland, and H. L. Malech, "Enhanced host defense after gene transfer in the murine p47(phox)-deficient model of chronic granulomatous disease, " Blood, vol. 89, no. 7, pp. 2268-2275, 1997.
129. S. Mukherjee and A. J. Thrasher, "Gene therapy for PIDs: progress, pitfalls and prospects, " Gene, vol. 525, no. 2, pp. 174-181, 2013.
130. L. M. Griffith, M. J. Cowan, L. D. Notarangelo, et al., "Primary Immune Deficiency Treatment Consortium (PIDTC) report, " The Journal of Allergy and Clinical Immunology, vol. 133, pp. 335-347, 2014.